107 related articles for article (PubMed ID: 8266318)
1. A monoclonal antibody with specificity to the HLA-DR1 and -DR51 antigens.
Loh MT; Chan SH; Ren EC
Tissue Antigens; 1993 Aug; 42(2):100-4. PubMed ID: 8266318
[TBL] [Abstract][Full Text] [Related]
2. The monoclonal antibody TAL16.1 recognizes the aspartic acid residue at position 70 in DRB gene products.
Sadler AM; Heyes JM; Marsh SG; Krausa P; Reynolds GE; Bodmer JG
Tissue Antigens; 1993 Jan; 41(1):42-6. PubMed ID: 7681224
[TBL] [Abstract][Full Text] [Related]
3. Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1?
Marrari M; Duquesnoy RJ
Hum Immunol; 2009 Jun; 70(6):403-9. PubMed ID: 19275922
[TBL] [Abstract][Full Text] [Related]
4. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
[TBL] [Abstract][Full Text] [Related]
5. Serologic and molecular studies of two kindreds expressing recombinant HLA DR1/DR2 haplotypes.
Wisecarver J; Shepherd S; Beisel K; Rubocki R
Tissue Antigens; 1993 Mar; 41(3):148-54. PubMed ID: 7686308
[TBL] [Abstract][Full Text] [Related]
6. Recognition of HLA-DR1/DRB1*0101 molecules presenting HLA-A2 derived peptides by a human recombinant antibody, Fab-5 A1.
Löffler D; Welschof M; Goldmann SF; Wölpl A
Eur J Immunogenet; 1998 Oct; 25(5):339-47. PubMed ID: 9805656
[TBL] [Abstract][Full Text] [Related]
7. Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling.
Jurcevic S; Travers PJ; Hills A; Agrewala JN; Moreno C; Ivanyi J
Int Immunol; 1996 Nov; 8(11):1807-14. PubMed ID: 8943576
[TBL] [Abstract][Full Text] [Related]
8. The absence of DR51 in a DRB5-positive individual DR2ES is caused by a null allele (DRB5*0108N).
Voorter CE; Roeffaers HE; du Toit ED; van den Berg-Loonen EM
Tissue Antigens; 1997 Oct; 50(4):326-33. PubMed ID: 9349614
[TBL] [Abstract][Full Text] [Related]
9. Apparent HLA DR triplet due to the coexpression of a DRB5-encoded molecule on a DR1 haplotype.
Gebuhrer L; Tiercy JM; Freidel AC; Labonne MP; Lambert J; Jeannet M; Betuel H
Hum Immunol; 1992 Jun; 34(2):91-8. PubMed ID: 1429037
[TBL] [Abstract][Full Text] [Related]
10. Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells.
Wölpl A; Halder T; Kalbacher H; Neumeyer H; Siemoneit K; Goldmann SF; Eiermann TH
Tissue Antigens; 1998 Mar; 51(3):258-69. PubMed ID: 9550326
[TBL] [Abstract][Full Text] [Related]
11. A supertypic HLA class II determinant shared by DR1 and DRw9, and crossreactive with DR2, defined by human monoclonal antibody.
Kosinski S; Yang SY; Pistillo MP; Hämmerling U
Hum Immunol; 1988 Mar; 21(3):221-31. PubMed ID: 2453492
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF; Whittington KB; Zaller DM; Kang AH
J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
[TBL] [Abstract][Full Text] [Related]
13. Mapping of an HLA-DRw52-associated determinant on DR beta 1 molecules.
Ballas M; Eiermann TH; Wölpl A; Goldmann SF
Tissue Antigens; 1990 Nov; 36(5):187-93. PubMed ID: 1710076
[TBL] [Abstract][Full Text] [Related]
14. A Comparative Analysis of the Peptide Repertoires of HLA-DR Molecules Differentially Associated With Rheumatoid Arthritis.
Scholz E; Mestre-Ferrer A; Daura X; García-Medel N; Carrascal M; James EA; Kwok WW; Canals F; Álvarez I
Arthritis Rheumatol; 2016 Oct; 68(10):2412-21. PubMed ID: 27158783
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody that detects a polymorphic determinant common to HLA-DR1 and 2.
Kasahara M; Ogasawara K; Ikeda H; Okuyama T; Ishikawa N; Takenouchi T; Wakisaka A; Kikuchi Y; Aizawa M
Tissue Antigens; 1983 Feb; 21(2):105-13. PubMed ID: 6189259
[TBL] [Abstract][Full Text] [Related]
16. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR51 expression failure caused by a two-base deletion at exon 2 of a DRB5 null allele (DRB5*0110N) in a Spanish gypsy family.
Balas A; Ocon P; Vicario JL; Alonso A
Tissue Antigens; 2000 May; 55(5):467-9. PubMed ID: 10885571
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in the anti-HLA-DR immune response elicited by the antiidiotypic monoclonal antibody F5-444. Analysis at the clonal level.
Mariani SM; Armandola EA; Ferrone S
Transplantation; 1992 Dec; 54(6):1078-84. PubMed ID: 1281563
[TBL] [Abstract][Full Text] [Related]
19. N-terminal amino acid sequences of the alpha and beta chains of HLA-DR1 and HLA-DR2 antigens.
Walker LE; Hewick R; Hunkapiller MW; Hood LE; Dreyer WJ; Reisfeld RA
Biochemistry; 1983 Jan; 22(1):185-8. PubMed ID: 6600932
[TBL] [Abstract][Full Text] [Related]
20. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
